[144] Asana, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice: A holder linked to early founders proposes to sell 14,500 shares of common stock on 10/10/2025, with an aggregate market value of $220,255.00. The shares were acquired as founders shares on 02/04/2009. The filing names Morgan Stanley Smith Barney LLC as the broker and lists total shares outstanding as 156,685,245, which frames the proposed sale as immaterial to total supply.

The filing also discloses a series of prior Rule 10b5-1 sales attributed to Justin Rosenstein across 07/18/2025–10/09/2025, with multiple transactions and gross proceeds reported (individual proceeds listed). The filer attests there is no undisclosed material adverse information and notes compliance language about Rule 10b5-1 plans.

Insights

Insider Transactions Compliance Specialist

TL;DR: Routine founder sale under Rule 144 with prior 10b5-1 activity disclosed.

The filing documents a proposed sale of 14,500 founder shares acquired on 02/04/2009, using Morgan Stanley as broker and targeting 10/10/2025 for execution. The size ($220,255) is small relative to the reported 156,685,245 outstanding shares, indicating limited direct market impact.

Multiple prior Rule 10b5-1 sales for Justin Rosenstein between 07/18/2025 and 10/09/2025 are listed with reported gross proceeds, demonstrating ongoing prearranged sales. Key items to watch near term are the actual trade execution on 10/10/2025 and any subsequent Form 4 filings that report the post-sale beneficial ownership.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14500	220255.00	156685245	10/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/04/2009	Founders Shares	Issuer			14500	02/04/2009	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JUSTIN ROSENSTEIN 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	10/09/2025	1199560	18274816.78
10b5-1 Sales for JUSTIN ROSENSTEIN 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	10/08/2025	454913	6860861.39
10b5-1 Sales for JUSTIN ROSENSTEIN 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	07/28/2025	517635	7783936.31
10b5-1 Sales for JUSTIN ROSENSTEIN 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	07/25/2025	223894	3353305.22
10b5-1 Sales for JUSTIN ROSENSTEIN 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	07/24/2025	115936	1743051.39
10b5-1 Sales for JUSTIN ROSENSTEIN 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	07/23/2025	729228	10996831.16
10b5-1 Sales for JUSTIN ROSENSTEIN 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	07/22/2025	966576	14536529.78
10b5-1 Sales for JUSTIN ROSENSTEIN 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	07/21/2025	195131	2928194.33
10b5-1 Sales for JUSTIN ROSENSTEIN 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	07/18/2025	226600	3396598.04

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)